Parent Drug and Active Metabolite (FDA) [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2006-05-10 10:22 (7357 d 08:02 ago) – Posting: # 123
Views: 11,804

❝ […] would this mean that ANOVA on the metabolite data is not necessary?


Hi Joy,

yes, IMHO no confidence interval of the metabolite; you should present just means, standard deviations, etc. If you opt to present a confidence interval make clear in the protocol, that there's no acceptance range for it.

The wonderful thing about FDA is that you have to present the study protocol to them anyhow; if they don't like it, they will tell you ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
224 visitors (0 registered, 224 guests [including 13 identified bots]).
Forum time: 18:24 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5